Medical Policy Update
Blue Cross and Blue Shield of Kansas (BCBSKS) has published the following updated medical policies on the BCBSKS Website. Click on a link to view the details of each policy.
Published 12/29/22:
- Analysis of Human DNA in Stool Samples as a Technique for Colorectal Cancer Screening
- Bone Mineral Density Studies
- Diagnosis and Treatment of Sacroiliac Joint Pain
- Drug Testing in Pain Management and Substance Use Disorder Treatment
- Endoscopic Radiofrequency Ablation or Cryoablation for Barrett Esophagus
- Esophageal pH Monitoring
- Facet Joint Denervation
- Gene Expression Profiling and Protein Biomarkers for Prostate Cancer Management
- Genetic and Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate Cancer
- Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Disorders
- Measurement of Serum Antibodies to Selected Biologic Agents
- Monitored Anesthesia Care
- Noninvasive Techniques for the Evaluation and Monitoring of Patients with Chronic Liver Disease
- Proteomic Testing for Systemic Therapy in Non-Small-Cell Lung Cancer
- Sphenopalatine Ganglion Block for Headache
- Transcranial Magnetic Stimulation (TMS) as a Treatment of Depression and Other Psychiatric/Neurologic Disorders
If you have questions regarding this publication, please contact your BCBSKS provider consultant/representative.